Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 1
2005 2
2007 5
2008 5
2009 2
2010 3
2011 6
2012 3
2013 5
2014 3
2015 4
2016 6
2017 4
2018 8
2019 4
2020 7
2021 3
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Results by year
Filters applied: . Clear all
Page 1
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial.
Rizvi NA, Cho BC, Reinmuth N, Lee KH, Luft A, Ahn MJ, van den Heuvel MM, Cobo M, Vicente D, Smolin A, Moiseyenko V, Antonia SJ, Le Moulec S, Robinet G, Natale R, Schneider J, Shepherd FA, Geater SL, Garon EB, Kim ES, Goldberg SB, Nakagawa K, Raja R, Higgs BW, Boothman AM, Zhao L, Scheuring U, Stockman PK, Chand VK, Peters S; MYSTIC Investigators. Rizvi NA, et al. Among authors: le moulec s. JAMA Oncol. 2020 May 1;6(5):661-674. doi: 10.1001/jamaoncol.2020.0237. JAMA Oncol. 2020. PMID: 32271377 Free PMC article. Clinical Trial.
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non-small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study.
Cortot AB, Audigier-Valette C, Molinier O, Le Moulec S, Barlesi F, Zalcman G, Dumont P, Pouessel D, Poulet C, Fontaine-Delaruelle C, Hiret S, Dixmier A, Renault PA, Becht C, Raffy O, Dayen C, Mazieres J, Pichon E, Langlais A, Morin F, Moro-Sibilot D, Besse B. Cortot AB, et al. Among authors: le moulec s. Eur J Cancer. 2020 May;131:27-36. doi: 10.1016/j.ejca.2020.02.022. Epub 2020 Apr 8. Eur J Cancer. 2020. PMID: 32276179 Clinical Trial.
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study.
Morgensztern D, Besse B, Greillier L, Santana-Davila R, Ready N, Hann CL, Glisson BS, Farago AF, Dowlati A, Rudin CM, Le Moulec S, Lally S, Yalamanchili S, Wolf J, Govindan R, Carbone DP. Morgensztern D, et al. Among authors: le moulec s. Clin Cancer Res. 2019 Dec 1;25(23):6958-6966. doi: 10.1158/1078-0432.CCR-19-1133. Epub 2019 Sep 10. Clin Cancer Res. 2019. PMID: 31506387 Free PMC article. Clinical Trial.
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.
Ferrara R, Mezquita L, Texier M, Lahmar J, Audigier-Valette C, Tessonnier L, Mazieres J, Zalcman G, Brosseau S, Le Moulec S, Leroy L, Duchemann B, Lefebvre C, Veillon R, Westeel V, Koscielny S, Champiat S, Ferté C, Planchard D, Remon J, Boucher ME, Gazzah A, Adam J, Bria E, Tortora G, Soria JC, Besse B, Caramella C. Ferrara R, et al. Among authors: le moulec s. JAMA Oncol. 2018 Nov 1;4(11):1543-1552. doi: 10.1001/jamaoncol.2018.3676. JAMA Oncol. 2018. PMID: 30193240 Free PMC article.
[Craniopharyngiomas: role of radiotherapy].
Chargari C, Bauduceau O, Bauduceau B, Camparo P, Ceccaldi B, Fayolle M, Le Moulec S, Védrine L. Chargari C, et al. Among authors: le moulec s. Bull Cancer. 2007 Nov;94(11):987-94. Bull Cancer. 2007. PMID: 18055317 Free article. Review. French.
[Cell cycle and molecular targets: CDK inhibition].
Carassou P, Meijer L, Le Moulec S, Aoun J, Bengrine-Lefèvre L. Carassou P, et al. Among authors: le moulec s. Bull Cancer. 2012 Feb 1;99(2):163-71. doi: 10.1684/bdc.2011.1383. Bull Cancer. 2012. PMID: 21737380 Free article. Review. French.
[Neuroendocrine carcinoma of the digestive tract: a literature review].
Jacob J, Chargari C, Helissey C, Ferrand FR, Ceccaldi B, Le Moulec S, Bauduceau O, Fayolle M, Védrine L. Jacob J, et al. Among authors: le moulec s. Rev Med Interne. 2013 Nov;34(11):700-5. doi: 10.1016/j.revmed.2013.02.013. Epub 2013 Jul 18. Rev Med Interne. 2013. PMID: 23871177 Review. French.
[Craniopharyngioma].
Chargari C, Bauduceau O, Le Moulec S, Vedrine L, Ceccaldi B. Chargari C, et al. Among authors: le moulec s. Rev Prat. 2007 Oct 31;57(16):1756. Rev Prat. 2007. PMID: 18092716 French. No abstract available.
[Fever and cancer: components of diagnosis for optimal management].
Moussaid Y, Bertaux M, Chargari C, Helissey C, Le Moulec S, Errihani H, Vedrine L. Moussaid Y, et al. Among authors: le moulec s. Rev Med Interne. 2013 Sep;34(9):545-52. doi: 10.1016/j.revmed.2012.10.368. Epub 2012 Nov 27. Rev Med Interne. 2013. PMID: 23199412 Review. French.
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
Thurin NH, Bosco-Levy P, Blin P, Rouyer M, Jové J, Lamarque S, Lignot S, Lassalle R, Abouelfath A, Bignon E, Diez P, Gross-Goupil M, Soulié M, Roumiguié M, Le Moulec S, Debouverie M, Brochet B, Guillemin F, Louapre C, Maillart E, Heinzlef O, Moore N, Droz-Perroteau C. Thurin NH, et al. Among authors: le moulec s. BMC Med Res Methodol. 2021 May 1;21(1):95. doi: 10.1186/s12874-021-01285-y. BMC Med Res Methodol. 2021. PMID: 33933001 Free PMC article.
71 results